CP - then you take into account the ease of transitioning doctors/sites from SUNRISE to these various PPHM/AZN trials and how much does that save regarding time and manpower?
I'd say 50% nails it IMO. And that's on a non-exclusive deal.
The PPS is what is is because of dilutionary factors that cannot be denied but to say PPHM didn't get a great deal is quite another.
Market Data 
Markets 
AI
